Notably, knockout or inhibition of the IDO pathway improves intestinal injury and its metabolic disorder in mice (Laurans et al.2018), while Ido1-/- mice develop aggravated colitis (Takamatsu et al.2013). Here, IDO1 is linked to colitis.